Related Experiment Video

Updated: Aug 10, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1)

M A Greeve1, R K Allan, J M Harvey

  • 1Department of Anatomical Pathology, Royal Perth Hospital, Wellington Street, Perth, Western Australia 6000, Australia.

Journal of Molecular Endocrinology
|June 3, 2004
PubMed

Insights

Androgens like 5alpha-dihydrotestosterone (DHT) inhibit breast cancer cell growth by affecting cell cycle progression. DHT increases levels of the Cdk inhibitor p27(Kip1), impacting cyclin-dependent kinases and mediating growth inhibition.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Androgens are known to inhibit breast cancer cell growth through poorly understood mechanisms.
  • Understanding these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which androgens, specifically 5alpha-dihydrotestosterone (DHT), inhibit breast cancer cell proliferation.
  • To investigate the effects of DHT on cell cycle progression and the role of cyclin-dependent kinases (Cdks) and their inhibitors.

Main Methods:

  • Treatment of MCF-7 breast cancer cells with DHT.
  • Analysis of cell proliferation, cell cycle phase distribution (G1/S transition), and Cdk kinase activities.
  • Quantification of Cdk inhibitors p27(Kip1) and p21(Cip1/Waf1) protein levels and their association with Cdk complexes.

Main Results:

  • DHT inhibited MCF-7 cell proliferation and increased the proportion of cells in the G1 phase.
  • DHT reduced the kinase activities of Cdk4 and Cdk2 and increased levels of the Cdk inhibitor p27(Kip1).
  • DHT altered the association of p21(Cip1/Waf1) and p27(Kip1) with Cdk2 and Cdk4 complexes, suggesting a reversal of Cdk4-mediated titration.

Conclusions:

  • DHT-induced breast cancer cell growth inhibition is partly mediated by the increased association of p21(Cip1/Waf1) with Cdk2 complexes.
  • Androgen signaling impacts cell cycle regulation through modulation of Cdk inhibitors and their interactions with Cdks.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...